๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Colchicine in primary biliary cirrhosis

โœ Scribed by T. W. WARNES


Book ID
108603017
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
611 KB
Volume
5
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A randomized trial comparing colchicine
โœ R E Poupon; P M Huet; R Poupon; A Bonnand; J T Van Nhieu; E S Zafrani ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 214 KB ๐Ÿ‘ 2 views

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2-year controlled study. Seventy-four patients with PBC who had been treated previously with UDCA (at least 8 months) b

Effect of colchicine on lymphocyte and m
โœ David Kershenobich; Marcos Rojkind; Alfonso Quiroga; Jorge Alcocer-Varela ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 558 KB

Lymphocyte and monocyte function was investigated in eight patients with primary biliary cirrhosis and in age-matched and sex-matched controls. In three of the eight cirrhotic patients, two were in the late stage of the disease (stage 111) and concanavalin A-induced s u p pressor cell function was m

Synthesis of interleukin-1ฮฒ in primary b
โœ Laurie C. Miller; Dr Archna Sharma; Augusta F. McKusick; Dr Joseph P. Tassoni; C ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 702 KB

Primary biliary cirrhosis (PBC) is a chronic, progressive, cholestatic liver disease. Interleukin-lp (JL-lp) may play a role in the pathogenesis of PBC by contributing to altered immune function and fibrosis. Colchicine or methotrexate has some beneficial effects in the treatment of PBC, and also af

A randomized controlled trial of colchic
โœ Marshall M. Kaplan; Steven Cheng; Lori Lyn Price; Peter A. L. Bonis ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB ๐Ÿ‘ 1 views

Primary biliary cirrhosis frequently progresses despite treatment with ursodeoxycholic acid (UDCA), the only approved therapy. Previous studies suggested that colchicine and methotrexate may improve biochemical tests of liver function, symptoms, and liver histology. The aim of the present study was